Targeted Epigenetic Modification to Improve Mesothelioma Responses to Immunotherapy

Project Details

StatusActive
Effective start/end date30/09/2029/09/22

Funding

  • US Department of Defense: AUD76,934.00
  • US Department of Defense: AUD181,591.00
  • US Department of Defense: AUD287,099.00